BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 26264581)

  • 1. The wasting continuum in heart failure: from sarcopenia to cachexia.
    von Haehling S
    Proc Nutr Soc; 2015 Nov; 74(4):367-77. PubMed ID: 26264581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms and treatment targets of muscle wasting and cachexia in heart failure: an overview.
    Ebner N; Elsner S; Springer J; von Haehling S
    Curr Opin Support Palliat Care; 2014 Mar; 8(1):15-24. PubMed ID: 24452279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cachexia and sarcopenia: mechanisms and potential targets for intervention.
    Argilés JM; Busquets S; Stemmler B; López-Soriano FJ
    Curr Opin Pharmacol; 2015 Jun; 22():100-6. PubMed ID: 25974750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review.
    Ali S; Garcia JM
    Gerontology; 2014; 60(4):294-305. PubMed ID: 24731978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum myostatin levels are independently associated with skeletal muscle wasting in patients with heart failure.
    Furihata T; Kinugawa S; Fukushima A; Takada S; Homma T; Masaki Y; Abe T; Yokota T; Oba K; Okita K; Tsutsui H
    Int J Cardiol; 2016 Oct; 220():483-7. PubMed ID: 27390974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
    Biolo G; Cederholm T; Muscaritoli M
    Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle wasting in cardiac cachexia.
    Strassburg S; Springer J; Anker SD
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1938-47. PubMed ID: 15927519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional status and its effects on muscle wasting in patients with chronic heart failure: insights from Studies Investigating Co-morbidities Aggravating Heart Failure.
    Saitoh M; Dos Santos MR; Ebner N; Emami A; Konishi M; Ishida J; Valentova M; Sandek A; Doehner W; Anker SD; von Haehling S
    Wien Klin Wochenschr; 2016 Dec; 128(Suppl 7):497-504. PubMed ID: 27853883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.
    Bowen TS; Schuler G; Adams V
    J Cachexia Sarcopenia Muscle; 2015 Sep; 6(3):197-207. PubMed ID: 26401465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle wasting in heart failure: An overview.
    von Haehling S; Steinbeck L; Doehner W; Springer J; Anker SD
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2257-65. PubMed ID: 23665153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Muscle wasting (sarcopenia/cachexia) and malnutrition: new insights into development and therapy].
    Rensing L; Ockenga J
    Dtsch Med Wochenschr; 2010 Aug; 135(33):1605-11. PubMed ID: 20717865
    [No Abstract]   [Full Text] [Related]  

  • 12. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF).
    Fülster S; Tacke M; Sandek A; Ebner N; Tschöpe C; Doehner W; Anker SD; von Haehling S
    Eur Heart J; 2013 Feb; 34(7):512-9. PubMed ID: 23178647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cachexia: an overview of recent developments.
    von Haehling S; Anker SD
    J Am Med Dir Assoc; 2014 Dec; 15(12):866-72. PubMed ID: 25455531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia.
    Thomas DR
    Clin Nutr; 2007 Aug; 26(4):389-99. PubMed ID: 17499396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complexity of treating wasting in ambulatory rehabilitation: Is it starvation, sarcopenia, cachexia or a combination of these conditions?
    Yaxley A; Miller MD; Fraser RJ; Cobiac L; Crotty M
    Asia Pac J Clin Nutr; 2012; 21(3):386-93. PubMed ID: 22705428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal consequences and prognosis of chronic heart failure.
    Attanasio P; Anker SD; Doehner W; von Haehling S
    Curr Opin Endocrinol Diabetes Obes; 2011 Jun; 18(3):224-30. PubMed ID: 21494135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catabolic signaling and muscle wasting after acute ischemic stroke in mice: indication for a stroke-specific sarcopenia.
    Springer J; Schust S; Peske K; Tschirner A; Rex A; Engel O; Scherbakov N; Meisel A; von Haehling S; Boschmann M; Anker SD; Dirnagl U; Doehner W
    Stroke; 2014 Dec; 45(12):3675-83. PubMed ID: 25352483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of muscle mass: Current developments in cachexia and sarcopenia focused on biomarkers and treatment.
    Drescher C; Konishi M; Ebner N; Springer J
    Int J Cardiol; 2016 Jan; 202():766-72. PubMed ID: 26474466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac cachexia: hic et nunc: "hic et nunc" - here and now.
    Loncar G; Springer J; Anker M; Doehner W; Lainscak M
    Int J Cardiol; 2015 Dec; 201():e1-12. PubMed ID: 26545926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.
    Anker MS; von Haehling S; Springer J; Banach M; Anker SD
    Int J Cardiol; 2013 Jan; 162(2):73-6. PubMed ID: 23174169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.